GeneMR

Bioscience Healthcare

GeneMR

   GENEMR, is a pioneer early cancer detection using groundbreaking liquid biopsy technology, which leverages next-generation circulating cfRNA biomarker analysis. Unlike traditional biopsies, GENEMR provides a non-invasive, fast, and reliable approach to early cancer risk assessment using a small blood sample. This revolutionary technique allows the detection and differentiation of over 25 cancer types at their earliest stages, enabling earlier intervention and potentially saving lives. Additionally, GENEMR can evaluate prognosis during or after treatment by analyzing changes in cfRNA profiles, offering valuable insights for personalized care plans.